Uji Masahito, Yokoyama Yukihiro, Ohbuchi Katsuya, Tsuchiya Kazuaki, Sadakane Chiharu, Shimobori Chika, Yamamoto Masahiro, Nagino Masato
Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Japan.
Tsumura Research Laboratories, Tsumura & Co., Ami, Japan.
Metabolomics. 2017 Nov 8;13(12):155. doi: 10.1007/s11306-017-1292-x.
In patients with obstructive jaundice, biliary drainage sometimes fails to result in improvement. A pharmaceutical-grade choleretic herbal medicine, Inchinkoto (ICKT), has been proposed to exert auxiliary effects on biliary drainage; however, its effects are variable among patients.
The aim of this study is to explore serum biomarkers that are associated with pharmaceutical efficacy of ICKT.
Obstructive jaundice patients who underwent external biliary decompression were enrolled (n = 37). ICKT was given orally 3 times a day at daily dose of 7.5 g. Serum and bile samples were collected before, 3 h after, and 24 h after ICKT administration. The concentrations of total bilirubin, direct bilirubin, and total bile acid in bile specimens were measured. Metabolites in serum samples were comprehensively profiled using LC-MS/MS and GC-MS/MS. Pharmacokinetic analysis of major ICKT components was also performed.
ICKT administration significantly decreased serum ALT and increased bile volume after 24 h. The serum concentrations of ICKT components were not well correlated with the efficacy of ICKT. However, the ratio of 2-hydroxyisobutyric acid to arachidonic acid and the ratio of glutaric acid to niacinamide, exhibited good performance as biomarkers for the efficacy of ICKT on bile flow and ALT, respectively. Additionally, comprehensive correlation analysis revealed that serum glucuronic acid was highly correlated with serum total bilirubin, suggesting that this metabolite may be deeply involved in the pathogenesis of jaundice.
The present study indicates that ICKT is efficacious and provides candidates for predicting ICKT efficacy. Further validation studies are warranted.
在梗阻性黄疸患者中,胆汁引流有时未能带来病情改善。一种药用级利胆草药茵陈蒿汤(ICKT)已被提出可对胆汁引流发挥辅助作用;然而,其效果在患者中存在差异。
本研究旨在探索与ICKT药物疗效相关的血清生物标志物。
纳入接受体外胆汁减压的梗阻性黄疸患者(n = 37)。ICKT以每日7.5 g的剂量口服,每日3次。在给予ICKT之前、给药后3小时和24小时采集血清和胆汁样本。测量胆汁标本中总胆红素、直接胆红素和总胆汁酸的浓度。使用液相色谱 - 串联质谱法(LC-MS/MS)和气相色谱 - 串联质谱法(GC-MS/MS)对血清样本中的代谢物进行全面分析。还对ICKT主要成分进行了药代动力学分析。
给予ICKT 24小时后,血清谷丙转氨酶(ALT)显著降低,胆汁量增加。ICKT成分的血清浓度与ICKT的疗效相关性不佳。然而,2 - 羟基异丁酸与花生四烯酸的比值以及戊二酸与烟酰胺的比值,分别作为ICKT对胆汁流量和ALT疗效的生物标志物表现良好。此外,综合相关性分析显示血清葡萄糖醛酸与血清总胆红素高度相关,表明这种代谢物可能在黄疸发病机制中起重要作用。
本研究表明ICKT是有效的,并为预测ICKT疗效提供了候选生物标志物。有必要进行进一步的验证研究。